Every day, researchers are working to get a better understanding of celiac disease and its various presentations. Ongoing research is also exploring potential drug treatments for celiac disease.
Cour Pharmaceuticals discusses recent study data the the 16th International Celiac Disease Symposium (ICDS).
Dr. Benjamin Lebwohl answers questions about recent study findings linking celiac disease to neuropathy.
Check out NFCA's list of the top four highlights from Digestive Disease Week 2015.
Sanofi and Selecta Biosciences, Inc. collaborate on new immunotherapy for celiac disease.
The Jefferson Celiac Center is seeking participants for a research study.
Professor Detlef Schuppan, a member of NFCA's Research Summit Planning Committee, accepts the first international celiac disease prize awarded by the University of Tampere in Finland.
Tricia Thompson, MS, RD of Gluten-Free Watchdog answers common questions about arsenic in rice.
Company to develop AMG 714 for the treatment of diet non-responsive celiac disease and refractory celiac disease (celiac disease-triggered T-cell lymphoma).
New research on a screening method could improve the celiac disease diagnosis rate in children.
Emerging therapeutic company to initially focus on addressing the significant medical and socioeconomic needs of patients with celiac disease
CONNECT WITH NFCA
Advertise with us
© 2015 National Foundation for Celiac Awareness. All rights reserved.
The information found on this website is not intended to be a replacement or substitute for professional medical treatment or for professional medical advice relative to a specific medical condition. We urge you to always seek the advice of your physician. There is no replacement for personal medical treatment and advice from your personal physician.
This site was last updated on
. If you have questions email the webmaster. celiac disease | celiac disease symptoms | gluten free products
This site complies with the HONcode standard for trustworthy health information: verify here.